Inhibitor Therapeutics Inc

OTC: INTI    
Share price (4/24/24): $0.09    
Market cap (4/24/24): $14.8 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 2 pages Inhibitor Theraputics, Inc. Scientific Advisory Board Charter Adopted October 13, 2023
12/34/56
EX-3.1
from 8-K 17 pages Amended and Restated Bylaws of Inhibitor Theraputics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Certificate of Incorporation of Hedgepath Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Correction of Certificate of Designation, of Series B Convertible Preferred Stock of Hedgepath Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 10 pages Certificate of Designation of Series B Convertible Preferred Stock of Hedgepath Pharmaceuticals, Inc. Pursuant to Section 151(g) of the Delaware General Corporation Law Series B Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages State of Delaware Certificate of Amendment of Certificate of Incorporation of Hedgepath Pharmaceuticals, Inc
12/34/56
EX-3.3
from S-1/A 2 pages State of Delaware Certificate of Amendment of Certificate of Incorporation of Hedgepath Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 20 pages Second Amended and Restated Bylaws of Hedgepath Pharmaceuticals, Inc. (A Delaware Corporation) (Adopted Effective as of May 15, 2015) Article 1 Offices
12/34/56
EX-3.1
from 8-K 20 pages Amended and Restated Bylaws of Hedgepath Pharmaceuticals, Inc. (A Delaware Corporation) (Adopted Effective as of July 18, 2014) Article 1 Offices
12/34/56
EX-3.1
from 8-K 8 pages Amended and Restated Certificate of Designation of Series a Convertible Preferred Stock of Hedgepath Pharmaceuticals, Inc. Pursuant to Section 151(g) of the Delaware General Corporation Law
12/34/56
EX-3.4
from 8-K 2 pages State of Delaware Certificate of Ownership and Merger
12/34/56
EX-3.3
from 8-K 8 pages Certificate of Designation of Series a Convertible Preferred Stock of Hedgepath Pharmaceuticals, Inc. Pursuant to Section 151 of the Delaware General Corporation Law Series a Convertible Preferred Stock
12/34/56
EX-3.2
from 8-K 19 pages Bylaws of Hedgepath Pharmaceuticals, Inc. (A Delaware Corporation) (Adopted Effective as of July 30, 2013) Article 1 Offices
12/34/56
EX-3.1
from 8-K 6 pages Certificate of Incorporation of Hedgepath Pharmaceuticals, Inc
12/34/56
EX-3
from SC 13D 9 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 5 pages Articles of Amendment of Articles of Incorporation of Commonwealth Biotechnologies, Inc. III
12/34/56
EX-3.2
from 8-K 11 pages Commonwealth Biotechnologies, Inc. Third Amended and Restated Bylaws
12/34/56
EX-3.2
from 10KSB 11 pages Commonwealth Biotechnologies, Inc. Second Amended and Restated Bylaws
12/34/56
EX-3.(II)
from SB-2 ~10 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.(I)
from SB-2 ~5 pages Articles of Incorporation or Bylaws
12/34/56